China’s pharmaceutical contractors are showing financial resilience in the face of Washington’s push to curb reliance on Chinese supply chains. Analysts said investors were bullish because the US government’s recent measures to curb Beijing’s rise as a global pharmaceutical supplier had met resistance from industry players reluctant to…
China’s pharmaceutical contractors are showing financial resilience in the face of Washington’s push to curb reliance on Chinese supply chains. Analysts said investors were bullish because the US government’s recent measures to curb Beijing’s rise as a global pharmaceutical supplier had met resistance from industry players reluctant to…
China’s fixed-asset investment dropped by 6.7% year-on-year in the January to July 2026 period, worse than market expectations for a 6.2% fall and the 5.7% decline recorded in the first half of the year. Property investment remained the biggest drag, plunging 19.2% after an 18% decline in January-June, while infrastructure investment…